Furthermore, rodent models of diabetes show altered neuromodulation systems operated by adenosine [27–29], ATP [30], or endocannabinoids [31, 32], which control synaptic activity and brain energy metabolism, and might interact with brain insulin signaling [33]. This evidence concerns the gene INS and diabetes mellitus.